CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
about
Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis.IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer.OMIP-036: Co-inhibitory receptor (immune checkpoint) expression analysis in human T cell subsets.Gene expression markers of Tumor Infiltrating Leukocytes.T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.Regulation of the T Cell Response by CD39.Immunoregulatory functions of VISTA.Immune Regulation in Pregnancy: A Matter of Perspective?Successful and Maladaptive T Cell Aging.Current progress in host innate and adaptive immunity against hepatitis C virus infection.What Else Can CD39 Tell Us?Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation.T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection.Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice.Targeting immunosuppressive adenosine in cancer.Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8+ T-Cell Repertoire in Older People.Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection.Unravelling the fate of functional PD1+ T cells in chronic viral hepatitis.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.A Synthetic CD8α:MyD88 Coreceptor Enhances CD8+ T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens.T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma.T-Cell Dysfunction in Glioblastoma: Applying a New Framework.Tumor-infiltrating CD39+γδTregs are novel immunosuppressive T cells in human colorectal cancer.CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases.Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.Hepatitis C Vaccines, Antibodies, and T Cells.Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumorsInduction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
P2860
Q30276224-B7BEEAD9-7148-411B-8C57-39ECF74E77CCQ33769563-D16AA633-9505-4BC3-8828-8D5AA742F00EQ33779401-6FD35F3E-623E-47D0-B755-47543FAC1781Q36077705-57537910-D9B0-4005-B97D-EB9FC9B24A9CQ37687671-BD6C2D19-3A40-4888-8E0E-C906EE3636F3Q37732151-1FD411EB-0662-4FAA-9AEF-17348F66EE54Q38752940-90EFBEE5-2564-42CF-AC95-DA0430F88109Q38826175-4787965F-A715-4DE7-A520-1FDF1BC53511Q38847228-45724427-7B72-45F6-A1EB-F849B23850C3Q38930123-8287631E-158C-4EE3-822F-95A14C51D602Q38999649-1D7C1552-41F7-4F1C-9026-9B14F2855DDFQ39193878-4F6EDEA3-C5B6-41FD-8A17-DF8A57EE3907Q39393253-6EEB57FD-3678-4B15-8679-C95277DD7AB6Q39424529-038E24C9-C5F2-465C-98DF-BCCB3D569771Q40154614-889243A5-B90C-4D42-8E8F-192626447040Q40217589-99B6F44A-F2D2-4FA1-8E8C-0F2BAD5BF1D0Q40248504-FEF99D32-0258-4767-B941-42A7EBC6C132Q40330870-BC94D5CA-ACA5-4D37-B942-36539FE94328Q41990100-ADC08354-9D01-48CC-A9A3-605A49D571AEQ46140918-2AE86B33-6409-4C77-A657-17A488D4C931Q47221262-956F8714-4C2C-410D-82C5-FBA073DCC625Q47556008-BD1347D7-91FA-4347-93A6-9133801CF77DQ47557325-CF7581E0-8212-4AD6-B3D1-6511E93DA9E5Q47585968-D80814C9-FF89-4B60-9199-DD16D9A2930EQ47621514-7CCF56B7-0A2B-49A6-8120-FAB1958688D5Q50043938-A6297110-D629-44AE-AC0E-B7562297ACE3Q52625023-1ADD8D81-9854-46B6-8FA0-553743517A2DQ53399267-7A5F3FAC-42CB-4A65-95FC-04F20488393FQ54217234-7A0E5BFD-6A26-4CB5-9C05-9C8D273551DBQ55074024-FAD40267-63AF-46C7-8328-728BF76D0665Q55352762-02F16081-ED32-42D7-A437-DAF138D29615Q55709137-9C71BEF7-5A8C-4FF1-A8F7-D1E1576153B0Q57176182-AE940577-67BD-4CCF-AFDB-4FFFFAB63ADAQ57483649-386A3A13-BAFD-4374-B660-A6C58BE03066
P2860
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@ast
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@en
type
label
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@ast
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@en
prefLabel
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@ast
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@en
P2093
P2860
P1433
P1476
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
@en
P2093
Arlene H Sharpe
Carola Ledderose
Cormac Cosgrove
David Wolski
E John Wherry
Galit Alter
Georg M Lauer
Jernej Godec
Kathleen Yates
Kristen E Pauken
P2860
P304
P356
10.1371/JOURNAL.PPAT.1005177
P577
2015-10-20T00:00:00Z